LXRX - Lexicon Pharmaceuticals to Participate in the 35th Annual Piper Sandler Healthcare Conference and the 6th Annual Evercore ISI HealthCONx Conference | Benzinga

THE WOODLANDS, Texas, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced its participation in the following investor conferences taking place November 29 - December 1, 2023:

• 35^th Annual Piper Sandler Healthcare Conference
• 6^th Annual Evercore ISI HealthCONx Conference

Lonnel Coats, Lexicon's chief executive officer, Jeff Wade, Lexicon's president and chief financial officer, Tom Garner, Lexicon's senior vice president and chief commercial officer, and Craig Granowitz, M.D., Ph.D., Lexicon's senior vice president and chief medical officer, will participate in moderated discussions at the Evercore ISI conference on Tuesday, November 28^th, at 2:35 pm ET and at the Piper Sandler Conference on Thursday, November 30^th, at 9:30am ET.

A simultaneous webcast of both discussions will be available in the "Events" section of the Lexicon website at www.lexpharma.com/events, and a recording of the webcast will be available for two weeks following the original on-demand date.

About Lexicon Pharmaceuticals

Lexicon is a ...

Full story available on Benzinga.com